Impact of cancer treatments on reproductive and sexual health in young colorectal cancer patients
Official title: The Effects of Chemotherapy or Radiotherapy on Reproductive and Sexual Health of Early Onset Colorectal Cancer Patients
Run by Memorial Sloan Kettering Cancer Center · NCT04812912 · Data updated 2026-11-12
This study looks at how chemotherapy and radiation therapy affect the reproductive and sexual health of young people with early onset colorectal cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 7 sites (Basking Ridge, New Jersey and 6 other locations) |
| Status | Recruiting |
| Started | March 18, 2021 |
| Main results expected | March 18, 2027 |
| Study ends | March 18, 2027 |
| Registry record updated | April 7, 2026 |
| Trial ID | NCT04812912 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18-40 years who are premenopausal females or 18-50 years for males, diagnosed with colorectal adenocarcinoma and eligible for curative therapy.
✕Probably not a fit
Patients with prior systemic treatment for colorectal cancer or those with active secondary malignancies may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate how chemotherapy and radiation therapy affect reproductive and sexual health in individuals diagnosed with early onset colorectal cancer. Researchers will monitor changes in hormone levels and assess sexual and reproductive health through questionnaires. The goal is to gather valuable information that can enhance understanding of the implications of cancer treatments on fertility and overall quality of life for these patients.
Why it matters
Potential benefit: If successful, this study could provide insights that help improve reproductive health management for young colorectal cancer patients undergoing treatment.
How similar studies have gone: While there is ongoing research in the area of cancer treatment effects on reproductive health, this specific focus on early onset colorectal cancer is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-40 years of age and premenopausal (female) or 18-50 years of age (male) at time of diagnosis * Histologic diagnosis of colorectal adenocarcinoma * Able and willing to participate in the informed consent process * Eligible for curative adjuvant or neoadjuvant therapy for colon or rectal cancer * Willing and able to complete protocol questionnaires * Rectal patients only: Individuals who will be receiving chemotherapy, followed by chemoradiotherapy (ChemoRT) Exclusion Criteria: * Prior systemic treatment for this malignancy * Active or prior secondary malignancy * History of ovarian resection (if female) * Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception until the termination of gestation, confirmed by a positive hCG laboratory test.
Where it's running
-
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States Recruiting -
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States Recruiting -
Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States Recruiting -
Memorial Sloan Kettering Cancer Center at Suffolk - Commack
Commack, New York, United States Recruiting -
Memorial Sloan Kettering Westchester
Harrison, New York, United States Recruiting -
Memorial Sloan Kettering Cancer Center
New York, New York, United States Recruiting
Show 1 more location
-
Memorial Sloan Kettering Nassau
Rockville Centre, New York, United States Recruiting
Study contacts
- Principal investigator: Andrea Cercek, MD — Memorial Sloan Kettering Cancer Center
- Study coordinator: Andrea Cercek, MD
- Email: cerceka@mskcc.org
- Phone: 646-888-4189
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery
Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.
-
PRIORITY-CONNECT 2: virtual prehabilitation and recovery support for people having colorectal cancer surgery
This trial tests whether a personalised virtual prehabilitation and recovery program with exercise, nutrition, and mental health support can lower 30-day complications for people having colorectal cancer surgery compared with usual care.
-
Nocardia rubra cell wall skeleton added to prior second- or third-line therapy for potentially hazardous stable colorectal cancer
This test tries adding Nocardia rubra cell wall skeleton to prior second- or third-line treatments for adults with advanced colorectal cancer who have a potentially hazardous stable disease to see if it better controls their cancer.
-
Blood test for early detection of colorectal cancer and adenomas
This study is testing a new blood test to see if it can help find early signs of colorectal cancer and adenomas in people who are already scheduled for a colonoscopy.
-
Detecting early onset colorectal cancer using a blood test
This study is testing a new blood test that looks for specific markers to help find early signs of colorectal cancer in young adults.
-
Assessing minimal residual disease in colorectal cancer using blood tests
This study is testing if a blood test for cancer DNA can help doctors find out which colorectal cancer patients are at risk of their cancer coming back after surgery and if they need extra treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.